News & Updates
Showing Ophthalmology articles
Showing
Show Multimedia Only

Lutein/zeaxanthin an appropriate substitute for beta carotene in AREDS2
21 Jun 2022
Supplementation with lutein/zeaxanthin instead of beta carotene is safe and does not contribute to an increase in lung cancer risk while having a potential beneficial effect on the risk of progression to late age-related macular degeneration (AMD), according to data from the Age-Related Eye Disease Study 2 (AREDS2) study.
21 Jun 2022

Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
13 Jun 2022
In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.
13 Jun 2022







